SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Immunomedics (IMMU) - moderated
An SI Board Since September 2006
Posts SubjectMarks Bans Symbol
63283 354 15 IMMU
Emcee:  idahoranch1 Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
63151Like many here I have followed SRPT for a long time. Several timesI have been tjargonweary2June 26
63150I’m going to give it a little more time. I thought that’s where we were at arounOlecranon-June 26
63149I see this as a contrary indicator. I think the fear/panic trade is mostly donestockdoc77-June 26
63148$10 hahaha. Bring it on. Reminds me of BoA dumping on TGTX the past two years, aghettogoulash-June 26
63147HC Wainwright & Co. analyst Mitchell Kapoor downgrades Sarepta Therapeutics(luckydog881June 25
63146I'm in the same boat and averaged down earlier this year just to get whackedstockdoc773June 23
63145Well dammit, a week ago I was so secure that a SP of upper/mid 30’s was a solid Olecranon3June 18
63144From the WSJ today: New FDA Chief Wants to Fast-Track Some Drugs, Use More AI Cluckydog88-June 17
63143It’s a relatively small position so mostly averaging down here…erippetoe-June 16
63142as tempted as I am to buy more, I think I already own a lot ............ might luckydog881June 16
63141I also doubled my position today in taxable account…erippetoe-June 16
63140Was only holding 125 shares of SRPT at $100+. Added 400 today, now at 975. Theseghettogoulash1June 16
63139downgrades this morning: HC Wainwright Downgrades Sarepta Therapeutics to Sell luckydog881June 16
63138SRPT is 23 pre market: finance.yahoo.comluckydog88-June 16
63137themedicinemaker.com some quotes from RFK in the article: Speaking in a podcaluckydog881June 14
63136Thanks for the corrections, GG. I also fully agree with your characterization oOlecranon-June 13
63135So the common denominator here is not Elevidys, but the vector itself, which makghettogoulash1June 12
63134SRPT: A couple of corrections. Elevidys already has Full Approval in ambulatory ghettogoulash1June 12
63133Perhaps I was a little too glib in my first statement regarding SRPT risks. JusOlecranon1June 11
63132I’m going push back on that a little; the worst is just beginning.dorightbythem1June 11
63131That is certainly the hope. I have been increasing holdings in this range for aluckydog88-June 10
63130IMHO RFKJr’s worst is already priced in.Olecranon1June 10
63129well i guess the risk is RFK and the uncertainty he brings. this is what happenluckydog881June 9
63128IMHO, it’s rare to see a stock a stock like Sarepta with so much near/medium terOlecranon-June 9
63127came across this today: 03:01 PM EDT, 06/09/2025 (MT Newswires) -- Sarepta Therluckydog882June 9
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News